Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

Dr Alexander (Sandy) Douglas in a medical research laboratory

Dr Sandy Douglas was awarded a 5 year Wellcome Stage 2 Clinical Research Career Development Fellowship, receiving £1.3m of funding to investigate development of new vaccines against rabies and Epstein Barr virus. On the back of his strong fellowship application, he also was one of four recipients of a Wellcome-Beit prize, worth another £25k of funding. This prize is awarded annually to Wellcome’s strongest applicants across their range of intermediate-level clinical & non-clinical fellowship schemes.

Dr Sandy Douglas commented upon receiving the news: “I’m really grateful to Wellcome for the opportunity to start work on vaccines against Epstein Barr virus. As well as glandular fever the virus causes many cancers and seems to be a prerequisite for development of multiple sclerosis, but it’s a tricky target and has been quite neglected by vaccine developers. The Jenner & the wider NDM are the perfect setting to enable progress in this important area.”

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.